Trends in Opioid Prescribing In COVID-19 Survey

Question Title

* 1. What is your gender?

Male

Female

Prefer not to say

Question Title

* 2. What is your age?

Under 30

31-40

41-50

51-60

61-70

71-80

81+

Question Title

* 3. Which country do you practice medicine in?

Question Title

* 4. If located in the United States of America, what State do you practice medicine in?

Question Title

* 5. Which best describes your provider type:

Attending Physician

Physician in training

Nurse practitioner

Physicians assistant

Question Title

* 6. If you are a physician, are you Board Certified in Pain Medicine?

Yes

(If yes, please specify through which organization / entity)

Question Title

* 7. If you are a physician, did you complete an ACGME accredited Pain Management Fellowship?

Yes

N/A

Question Title

* 8. If you are a physician, what is your primary board specialty?

Anesthesiology

Physical Medicine & Rehabilitation

Neurology

Psychiatry

Other (please specify)

Question Title

* 9. What percentage of your clinical practice is dedicated to Pain Management?

0-20%

21-40%

41-60%

61-80%

81-100%

Question Title

* 10. How many years have you been in practice?

In Training

0-5 years

6-10 years

11-15 years

16-20 years

21-25 years

25+ years

Question Title

* 11. Prior to the COVID-19 pandemic (2019), did you prescribe opioids as part your pain management practice?

Yes

Question Title

* 12. Who typically prescribes opioid pain medications in your practice?

Physician

Nurse practitioner and/or Physician’s assistant

All of the above

Question Title

* 13. Prior to the COVID-19 pandemic (2019), to roughly what percentage of patients in your practice did you prescribe opioid pain medications?

100%

68-99%

34-67%

1-33%

Question Title

* 14. Prior to the COVID-19 pandemic (2019), roughly what percentage of your clinical time was spent performing interventional procedures / surgeries?

100%

68-99%

34-67%

1-33%

Question Title

* 15. Prior to the COVID-19 pandemic (2019), if you prescribed opioids in clinic, did you utilize opioid risk assessment tools / surveys?

Always (100%)

Usually (68-99%)

Sometimes (34-67%)

Rarely (1-33%)

Never (0%)

Question Title

* 16. During the COVID-19 pandemic, if you prescribed opioids via telemedicine, did you utilize opioid risk assessment tools / surveys?

Always (100%)

Usually (68-99%)

Sometimes (34-67%)

Rarely (1-33%)

Never (0%)

Question Title

* 17. Which opioid risk assessment tool do you typically use?

Opioid Risk Tool (ORT)

Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R)

Current Opioid Misuse Measure (COMM)

Prescription Drug Use Questionnaire-patient version (PDUQ-p)

I don’t use

Other (please specify)

Question Title

* 18. Prior to the COVID-19 pandemic (2019), how frequently did patients taking chronic opioid medications for pain present for follow up visits?

1-3 weeks

4 weeks

5-8 weeks

9-12 weeks

Greater than 12 weeks

Question Title

* 19. Prior to the COVID-19 pandemic (2019), how often did you perform a urine toxicology screen on a patient taking opioid pain medications?

Every visit

Random

Every 1-3 months

Every 3-6 months

Every 6-12 months

Greater than 12 months

Question Title

* 20. During the COVID-19 pandemic, have you changed the frequency which you perform urine drug screening?

Unchanged

Increased

Decreased

Holding on testing

Question Title

* 21. During the COVID-19 pandemic, was there a notable change in opioid compliance issues / violation?

No Change

Increase

Decrease

Question Title

* 22. Prior to the COVID-19 pandemic (2019), how often did you prescribe naloxone or anther opioid reversal agent with opioid pain medication prescriptions?

0-5 times per month

6-10 times per month

11-20 times per month

21-30 times per month

30+ times per month

Question Title

* 23. During the COVID-19 pandemic, has your prescription of opioid reversal agents, such as naloxone, changed?

No Change

Increase

Decrease

Question Title

* 24. During the COVID-19 pandemic, have you seen a change in the number of opioid prescriptions you dispensed for chronic pain?

No Change

Increase

Decrease

Question Title

* 25. During the COVID-19 pandemic, have you seen a change in the number of adverse reactions from opioids?

Increase

Decrease

No Change

Question Title

* 26. During the height of the COVID-19 pandemic (March-April 2020 in the United States), by what percentage did your interventional procedures / surgeries decrease?

1-20%

21-40%

41-60%

61-80%

81-100%

Question Title

* 27. During the COVID-19 pandemic (2019), if you had been able to freely perform elective interventional pain procedures/surgeries, would this have changed your prescribing habits for opioid medications?

Yes

Comment (optional)

Question Title

* 28. During the COVID-19 pandemic, have you prescribed chronic opioid therapy for medical conditions that you would not have prior to the pandemic?

Yes, once per week

Yes, once per day

Yes. More than once per day

If yes, specify condition(s):

Question Title

* 29. During the COVID-19 pandemic, did you change your opioid prescribing habits because of a patients’ delayed access to a planned surgery, such as a hip or knee replacement?

Yes

Describe the surgical population:

Question Title

* 30. During the COVID-19 pandemic, have you considered opioids as a temporary bridging treatment for those patients who were unable to proceed with a recommended elective pain procedures due to COVID-19?

Yes

What procedures did you most commonly defer?

Question Title

* 31. During the COVID-19 pandemic, have you noted a change in your total daily dose of opioid pain medications (total oral morphine mg equivalents) prescribed per patient?

No Change

Decreased

Increased

Question Title

* 32. During the COVID-19 pandemic, did you see a change in emergency / urgent care / hospital visits due to pain because of lack of access to interventional pain procedures?

No change

Increased

Decreased

Question Title

* 33. Prior to the COVID-19 pandemic (2019), where did you typically see your outpatient opioid pain medication patients?

In-patient

Office

Telemedicine

Telephone

Question Title

* 34. During the COVID-19 pandemic, where did you typically see your outpatient opioid pain medication patients?

In-Patient

Office

Telemedicine

Telephone

Question Title

* 35. Prior to the COVID-19 pandemic (2019), what percent of your practice was telemedicine?

0-25%

26-50%

51-75%

76-100%

Question Title

* 36. During the COVID-19 pandemic, what percent of your practice is now telemedicine?

0-25%

26-50%

51-75%

76-100%

Question Title

* 37. What is the maximum amount of oral morphine equivalents that you prescribe?

1-50

51-90

91+

Question Title

* 38. During the COVID-19 pandemic, for those patients who you feel are appropriate for chronic opioid therapy and prescribed greater than 50 oral morphine equivalents of opioids per day, have you typically been willing to refill these medications via telemedicine?

Yes